According to Vistin Pharma's latest financial reports and stock price the company's current Operating Margin is 22.05%. At the end of 2024 the company had an Operating Margin of 18.73%.
Year | Operating Margin | Change |
---|---|---|
2024 | 18.73% | 40.31% |
2023 | 13.35% | -739.24% |
2022 | -2.09% | -118% |
2021 | 11.60% | -123.63% |
2020 | -49.09% | -232.7% |
2019 | 36.99% | -186.29% |
2018 | -42.87% | -1129.14% |
2017 | 4.17% | -65.97% |
2016 | 12.24% | |
2014 | -23.34% | -754.13% |
2013 | 3.57% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.